Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of EUR 197.37 billion. The enterprise value is 220.09 billion.

Market Cap	197.37B
Enterprise Value	220.09B

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	Mar 11, 2025

Share Statistics

Current Share Class	1.96B
Shares Outstanding	n/a
Shares Change (YoY)	-2.90%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.87B

Valuation Ratios

The trailing PE ratio is 16.59 and the forward PE ratio is 13.91.

PE Ratio	16.59
Forward PE	13.91
PS Ratio	4.01
PB Ratio	5.55
P/TBV Ratio	n/a
P/FCF Ratio	12.12
P/OCF Ratio	11.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.50, with an EV/FCF ratio of 13.51.

EV / Earnings	18.50
EV / Sales	4.41
EV / EBITDA	10.50
EV / EBIT	13.22
EV / FCF	13.51

Financial Position

The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.81.

Current Ratio	0.79
Quick Ratio	0.50
Debt / Equity	0.81
Debt / EBITDA	1.40
Debt / FCF	1.78
Interest Coverage	16.83

Financial Efficiency

Return on equity (ROE) is 32.89% and return on invested capital (ROIC) is 16.23%.

Return on Equity (ROE)	32.89%
Return on Assets (ROA)	11.42%
Return on Invested Capital (ROIC)	16.23%
Return on Capital Employed (ROCE)	25.98%
Revenue Per Employee	648,907
Profits Per Employee	156,783
Employee Count	75,883
Asset Turnover	0.55
Inventory Turnover	2.24

Taxes

In the past 12 months, Novartis AG has paid 1.90 billion in taxes.

Income Tax	1.90B
Effective Tax Rate	13.80%

Stock Price Statistics

The stock price has increased by +34.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+34.19%
50-Day Moving Average	92.93
200-Day Moving Average	79.63
Relative Strength Index (RSI)	54.45
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of EUR 49.24 billion and earned 11.90 billion in profits. Earnings per share was 5.90.

Revenue	49.24B
Gross Profit	37.27B
Operating Income	16.42B
Pretax Income	13.80B
Net Income	11.90B
EBITDA	20.43B
EBIT	16.42B
Earnings Per Share (EPS)	5.90

Full Income Statement

Balance Sheet

The company has 6.60 billion in cash and 28.93 billion in debt, giving a net cash position of -22.33 billion.

Cash & Cash Equivalents	6.60B
Total Debt	28.93B
Net Cash	-22.33B
Net Cash Per Share	n/a
Equity (Book Value)	35.58B
Book Value Per Share	18.12
Working Capital	-6.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.58 billion and capital expenditures -1.29 billion, giving a free cash flow of 16.29 billion.

Operating Cash Flow	17.58B
Capital Expenditures	-1.29B
Free Cash Flow	16.29B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.68%, with operating and profit margins of 33.35% and 24.16%.

Gross Margin	75.68%
Operating Margin	33.35%
Pretax Margin	28.03%
Profit Margin	24.16%
EBITDA Margin	41.50%
EBIT Margin	33.35%
FCF Margin	33.08%

Dividends & Yields

This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.49%.

Dividend Per Share	3.50
Dividend Yield	3.49%
Dividend Growth (YoY)	6.06%
Years of Dividend Growth	3
Payout Ratio	60.27%
Buyback Yield	2.90%
Shareholder Yield	6.39%
Earnings Yield	6.03%
FCF Yield	8.25%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.71 and a Piotroski F-Score of 6.

Altman Z-Score	3.71
Piotroski F-Score	6